Home Cart Sign in  
Chemical Structure| 62013-04-1 Chemical Structure| 62013-04-1

Structure of Dirithromycin
CAS No.: 62013-04-1

Chemical Structure| 62013-04-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Dirithromycin is a semi-synthetic macrolide antibiotic pro-drug used to treat many different types of bacterial infections, such as bronchitis, pneumonia, tonsillitis, and even skin infections.

Synonyms: LY237216; Antibiotic AS-E 136

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Dirithromycin

CAS No. :62013-04-1
Formula : C42H78N2O14
M.W : 835.07
SMILES Code : CC1[C@@]([C@](O)([C@H](OC([C@@H]2C)=O)CC)C)([H])O[C@H](COCCOC)N[C@@]1([H])[C@](C[C@@](O)([C@@H]([C@@H](C)[C@]2([H])O[C@@](O[C@@H](C)[C@@H]3O)([H])C[C@@]3(C)OC)O[C@@](O[C@H](C)C[C@@H]4N(C)C)([H])[C@@H]4O)C)([H])C
Synonyms :
LY237216; Antibiotic AS-E 136
MDL No. :MFCD00865041

Safety of Dirithromycin

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H317
Precautionary Statements:P261-P280

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT02237768 Healthy Phase 1 Unknown December 2014 Jordan ... More >> Arab Pharmaceutical industry Consulting/ Pharmaceutical Research Unit Not yet recruiting Amman, Jordan, 11941 Principal Investigator: Rana T Bustami, Ph.D. Pharmacy Less <<
NCT02185846 Healthy Phase 1 Completed - Jordan ... More >> Arab Pharmaceutical industry Consulting/ Pharmaceutical Research Unit Amman, Jordan, 11941 Less <<
NCT02185833 Healthy Phase 1 Completed - Jordan ... More >> Arab Pharmaceutical industry Consulting/ Pharmaceutical Research Unit Amman, Jordan, 11941 Less <<
NCT02237807 Healthy Phase 1 Unknown October 2014 Jordan ... More >> Arab Pharmaceutical industry Consulting/ Pharmaceutical Research Unit Not yet recruiting Amman, Jordan, 11941 Principal Investigator: Rana T Bustami, Ph.D. Pharmacy Less <<
NCT02099240 Osteomyelitis Early Phase 1 Recruiting September 2019 United States, Kentucky ... More >> University of Louisville Recruiting Louisville, Kentucky, United States, 40202 Contact: Julio A Ramirez, MD    502-852-1148    jarami01@louisville.edu    Contact: David Seligson, MD    502-852-0923    d0seli01@louisville.edu    Sub-Investigator: Forest Arnold, DO          Sub-Investigator: Timothy Wiemkwn, PhD          Sub-Investigator: Robert Kelley, PhD          Sub-Investigator: James Summersgill, PhD          Sub-Investigator: Ruth Carrico, PhD          Sub-Investigator: Julie Harting, PharmD          Sub-Investigator: Paula Peyrani, MD          Principal Investigator: David Seligson, MD          Sub-Investigator: Craig Roberts, MD          Principal Investigator: Julio Ramirez, MD Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.20mL

0.24mL

0.12mL

5.99mL

1.20mL

0.60mL

11.98mL

2.40mL

1.20mL

References

 

Historical Records

Categories